- Home
- PHAT vs MOVE Comparison
PHAT vs MOVE Comparison
Compare PHAT & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHAT | MOVE |
|---|---|---|
| Founded | 2018 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 894.0M | 901.4M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PHAT | MOVE |
|---|---|---|
| Price | $12.08 | $13.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $19.83 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 50.5K |
| Earning Date | 04-30-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.72 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $175,110,000.00 | $433,000.00 |
| Revenue This Year | $93.04 | $1,460.71 |
| Revenue Next Year | $58.91 | $96.77 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 216.93 | N/A |
| 52 Week Low | $3.69 | $0.51 |
| 52 Week High | $18.31 | $34.87 |
Technical Indicators
Market Signals| Indicator | PHAT | MOVE |
|---|---|---|
| Relative Strength Index (RSI) | 50.49 | 46.74 |
| Support Level | $10.38 | $12.50 |
| Resistance Level | $12.44 | $15.51 |
| Average True Range (ATR) | 1.03 | 1.32 |
| MACD | -0.01 | -0.39 |
| Stochastic Oscillator | 64.24 | 24.52 |
Price Performance
Historical ComparisonAbout PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About MOVE Movano Inc.
Corvex Inc is an AI cloud computing company specializing in GPU accelerated infrastructure for AI workloads. The company provides AI-focused computing infrastructure that offers scalable computational resources. Its platform uses GPU-accelerated compute clusters and high-throughput storage to support performance, security, and efficiency at scale. The company's product portfolio includes GPU Clusters, Inference-as-a-Service, Confidential Computing, and GPU Node.